Literature DB >> 18802102

Cathelicidin administration protects mice from Bacillus anthracis spore challenge.

Mark W Lisanby1, Melissa K Swiecki, Brian L P Dizon, Kathryn J Pflughoeft, Theresa M Koehler, John F Kearney.   

Abstract

Cathelicidins are a family of cationic peptides expressed in mammals that possess numerous bactericidal and immunomodulatory properties. In vitro analyses showed that human, mouse, and pig cathelicidins inhibited Bacillus anthracis bacterial growth at micromolar concentrations in the presence or absence of capsule. Combined in vitro analyses of the effects of each peptide on spore germination and vegetative outgrowth by time lapse phase contrast microscopy, transmission electron microscopy, and flow cytometric analysis showed that only the pig cathelicidin was capable of directly arresting vegetative outgrowth and killing the developing bacilli within the confines of the exosporium. C57BL/6 mice were protected from spore-induced death by each cathelicidin in a time- and dose-dependent manner. Protection afforded by the porcine cathelicidin was due to its bactericidal effects, whereas the human and mouse cathelicidins appeared to mediate protection through increased recruitment of neutrophils to the site of infection. These findings suggest that cathelicidins might be utilized to augment the initial innate immune response to B. anthracis spore exposure and prevent the development of anthrax.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802102      PMCID: PMC4225133          DOI: 10.4049/jimmunol.181.7.4989

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

Authors:  D A Steinberg; M A Hurst; C A Fujii; A H Kung; J F Ho; F C Cheng; D J Loury; J C Fiddes
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide.

Authors:  J W Ezzell; T G Abshire; S F Little; B C Lidgerding; C Brown
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences.

Authors:  Chun Kim; Nadesan Gajendran; Hans-Willi Mittrücker; Matthias Weiwad; Young-Hwa Song; Robert Hurwitz; Matthias Wilmanns; Gunter Fischer; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

4.  Identification of a new member of the protegrin family by cDNA cloning.

Authors:  C Zhao; L Liu; R I Lehrer
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

5.  Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

Authors:  J Turner; Y Cho; N N Dinh; A J Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.

Authors:  Sara Heninger; Melissa Drysdale; Julie Lovchik; Julie Hutt; Mary F Lipscomb; Theresa M Koehler; C Rick Lyons
Journal:  Infect Immun       Date:  2006-08-21       Impact factor: 3.441

7.  Anthrax lethal factor inhibition.

Authors:  W L Shoop; Y Xiong; J Wiltsie; A Woods; J Guo; J V Pivnichny; T Felcetto; B F Michael; A Bansal; R T Cummings; B R Cunningham; A M Friedlander; C M Douglas; S B Patel; D Wisniewski; G Scapin; S P Salowe; D M Zaller; K T Chapman; E M Scolnick; D M Schmatz; K Bartizal; M MacCoss; J D Hermes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

8.  Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.

Authors:  Kahori Kurosaka; Qian Chen; Felix Yarovinsky; Joost J Oppenheim; De Yang
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

9.  Characterization of the exosporium basal layer protein BxpB of Bacillus anthracis.

Authors:  Christopher T Steichen; John F Kearney; Charles L Turnbough
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

10.  A bacteriolytic agent that detects and kills Bacillus anthracis.

Authors:  Raymond Schuch; Daniel Nelson; Vincent A Fischetti
Journal:  Nature       Date:  2002-08-22       Impact factor: 49.962

View more
  15 in total

1.  Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery.

Authors:  Christopher J Morris; Konrad Beck; Marc A Fox; David Ulaeto; Graeme C Clark; Mark Gumbleton
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

2.  Human transferrin confers serum resistance against Bacillus anthracis.

Authors:  Suzan H M Rooijakkers; Suzanne L Rasmussen; Shauna M McGillivray; Thomas B Bartnikas; Anne B Mason; Arthur M Friedlander; Victor Nizet
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

3.  ClpX contributes to innate defense peptide resistance and virulence phenotypes of Bacillus anthracis.

Authors:  Shauna M McGillivray; Celia M Ebrahimi; Nathan Fisher; Mojgan Sabet; Dawn X Zhang; Yahua Chen; Nina M Haste; Raffi V Aroian; Richard L Gallo; Donald G Guiney; Arthur M Friedlander; Theresa M Koehler; Victor Nizet
Journal:  J Innate Immun       Date:  2009-06-18       Impact factor: 7.349

4.  Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.

Authors:  Julie A Lovchik; Melissa Drysdale; Theresa M Koehler; Julie A Hutt; C Rick Lyons
Journal:  Infect Immun       Date:  2012-04-23       Impact factor: 3.441

5.  Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function.

Authors:  Nicholas W Kin; Yao Chen; Emily K Stefanov; Richard L Gallo; John F Kearney
Journal:  Eur J Immunol       Date:  2011-08-31       Impact factor: 5.532

6.  Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.

Authors:  Steven B Yee; David N Dyer; Nancy A Twenhafel; M Louise M Pitt
Journal:  Comp Med       Date:  2013-06       Impact factor: 0.982

Review 7.  Acinetobacter baumannii: an emerging opportunistic pathogen.

Authors:  Aoife Howard; Michael O'Donoghue; Audrey Feeney; Roy D Sleator
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

8.  Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.

Authors:  Matthew A Crawford; Marie D Burdick; Ian J Glomski; Anne E Boyer; John R Barr; Borna Mehrad; Robert M Strieter; Molly A Hughes
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

9.  Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.

Authors:  Jianghui Wang; Emily S W Wong; Jane C Whitley; Jian Li; Jessica M Stringer; Kirsty R Short; Marilyn B Renfree; Katherine Belov; Benjamin G Cocks
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

Review 10.  Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.

Authors:  Fern Findlay; Lorna Proudfoot; Craig Stevens; Peter G Barlow
Journal:  Pathog Glob Health       Date:  2016-06-17       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.